BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2019 10:37:20 AM | Browse: 1017 | Download: 1584
 |
Received |
|
2018-11-25 07:16 |
|
Peer-Review Started |
|
2018-11-26 05:56 |
|
To Make the First Decision |
|
2018-12-11 01:06 |
|
Return for Revision |
|
2018-12-11 07:58 |
|
Revised |
|
2019-01-16 17:47 |
|
Second Decision |
|
2019-01-22 10:52 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-01-28 15:47 |
|
Articles in Press |
|
2019-01-28 15:47 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-03-27 05:36 |
|
Publish the Manuscript Online |
|
2019-03-27 10:37 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
John Paul Haydek, Cesar Taborda, Rushikesh Shah, Preeti A Reshamwala, Morgan L McLemore, Fuad El Rassi and Saurabh Chawla |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Saurabh Chawla, FACG, MD, Associate Professor, Division of Digestive Diseases, Department of Internal Medicine, Emory University School of Medicine, 49 Jesse Hill Jr. Drive, Suite 431, Atlanta, GA 30303, United States. saurabh.chawla@emory.edu |
| Key Words |
Sickle cell disease; Sickle cell hepatopathy; Liver diseases; Extreme hyperbilirubinemia; Mortality |
| Core Tip |
Sickle cell hepatopathy is a rarely studied complication of sickle cell disease. Little is known about prognostic factors related to it. In our study, we identified patients with one indicator of sickle cell hepatopathy, extreme hyperbilirubinemia, and analyzed outcomes related to their clinical state. High levels of bilirubin are indicative of elevated morbidity and need for blood transfusion among patients with sickle cell disease. |
| Publish Date |
2019-03-27 10:37 |
| Citation |
Haydek JP, Taborda C, Shah R, Reshamwala PA, McLemore ML, El Rassi F, Chawla S. Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease. World J Hepatol 2019; 11(3): 287-293 |
| URL |
https://www.wjgnet.com/1948-5182/full/v11/i3/287.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v11.i3.287 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
